Overview

Rehabilitation Study in MS Patients

Status:
Terminated
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
Studying the effectiveness of a functional rehabilitation protocol (FRP) in early Relapsing Remitting Multiple Sclerosis (RRMS) patients treated with Betaferon by comparing the physical ability of patients with and without FRP.
Phase:
Phase 4
Details
Lead Sponsor:
Bayer
Treatments:
Interferon beta-1b
Interferon-beta
Interferons